Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS EQUITY (Details 4)

v3.21.1
STOCKHOLDERS EQUITY (Details 4) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Total stock-based compensation expense $ 2,855,122 $ 2,650,777
Cost of goods sold [Member]    
Total stock-based compensation expense 242,935 191,843
Research and Development [Member]    
Total stock-based compensation expense 471,146 360,569
Selling, General and Administrative [Member]    
Total stock-based compensation expense 2,107,577 2,047,025
Plasma Center Operating Expenses [Member]    
Total stock-based compensation expense $ 33,464 $ 51,340